Improving decision-making in youth psychotherapy
Enhancing Clinical Decision-Making in Modular Youth Psychotherapy
This study is looking at how to make therapy better for kids and teens with different mental health challenges by helping therapists pick the best treatment options that fit each child's unique needs and family situation.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard University NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-11013303 on NIH RePORTER |
What this research studies
This research focuses on enhancing the effectiveness of modular psychotherapy for children and adolescents with multiple mental health disorders. It aims to personalize treatment by allowing therapists to select from various therapeutic elements based on individual needs and family characteristics. The study will investigate how to improve decision-making processes for clinicians when choosing these treatment elements, particularly in cases where traditional methods have not been as effective. By analyzing data from past treatments and client assessments, the research seeks to provide better guidance for therapists.
Who could benefit from this research
Good fit: Ideal candidates for this research are children and adolescents aged 0-11 years who are experiencing anxiety, depression, or other mental health disorders.
Not a fit: Patients who do not have mental health disorders or those outside the age range of 0-11 years may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized psychotherapy treatments for children and adolescents with mental health issues.
How similar studies have performed: Previous research has shown that modular approaches like MATCH can significantly improve outcomes when supported by expert guidance, indicating potential for success in this area.
Where this research is happening
Cambridge, United States
- Harvard University — Cambridge, United States (Active)
Researchers
- Principal investigator: Venturo-Conerly, Katherine Elizabeth — Harvard University
- Study coordinator: Venturo-Conerly, Katherine Elizabeth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.